BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//SciLifeLab - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:SciLifeLab
X-ORIGINAL-URL:https://www.scilifelab.se
X-WR-CALDESC:Events for SciLifeLab
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/Stockholm
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20210328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20211031T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20220327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20221030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20230326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20231029T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/Stockholm:20220914T140000
DTEND;TZID=Europe/Stockholm:20220914T150000
DTSTAMP:20260408T033009
CREATED:20220905T092055Z
LAST-MODIFIED:20220906T122905Z
UID:142076-1663164000-1663167600@www.scilifelab.se
SUMMARY:Systems Analysis of Human Metabolism for Identification of Drug Targets and Biomarkers
DESCRIPTION:Systems Analysis of Human Metabolism for Identification of Drug Targets and Biomarkers \n\n\n\nWelcome to a lecture by Professor Jens Nielsen\, \n\n\n\nBioinnovation Institute\, Copenhagen\, Denmark. \n\n\n\n \n\n\n\n \n\n\n\n\n\n\n\nJens Nielsen is MSc in Chemical Engineering and PhD (1989) in Biochemical Engineering from the Danish Technical University (DTU). Fulbright visiting professor at MIT in 1995-1996. Professor at DTU in 1998. In 2008 he was recruited as Professor to Chalmers University of Technology\, Sweden. In 2015 he was founding Head of the Department of Biology and Biological Engineering\, which now encompass more than 200 people. Jens Nielsen was also a co-founder of the Novo Nordisk Foundation Center for Biosustainability that now have more than 300 people affiliated\, for which he served as CSO 2013-2018. From 2019 CEO of the BioInnovation Institute in Denmark\, which is a new institute financed by USD0.5B that fosters translational research and support new spin-out companies in life sciences. He has trained more than 280 scientists in his research group and published >850 publications that have been cited more than 98\,000 times (current H-factor 142). Inventor of >50 patents and founder of seven biotech companies. Has received numerous awards\, including the ENI Award\, the Eric and Sheila Samson Prime Minister Prize for Transportation Fuels\, the Novozymes Prize\, and the Gold Medal from the Royal Swedish Academy of Engineering Sciences. Member of 12 academies\, including NAS\, NAE\, Chinese Academy of Engineering\, EMBO and Royal Swedish Academy of Science. He will discuss the challenges of using systems medicine for advancing the development of personalized and precision medicine\, and it will be illustrated how the concept of genome-scale metabolic models can be used for integrative analysis of big data with the objective of identifying novel biomarkers that are foundational for personalized and precision medicine. \n\n\n\nThis keynote lecture is part of the FEBS Advanced Course – Exploring the Human Proteome
URL:https://www.scilifelab.se/event/systems-analysis-of-human-metabolism-for-identification-of-drug-targets-and-biomarkers/
LOCATION:Air&Fire\, SciLifeLab Stockholm\, Tomtebodavägen 23A\, Solna\, Sweden
CATEGORIES:Event
ATTACH;FMTTYPE=image/png:https://www.scilifelab.se/wp-content/uploads/2022/04/FEBS-Advanced-course.png
END:VEVENT
END:VCALENDAR